Horizon Pharma Files Patent Infringement Suit Against Par

by Benzinga Staff
March 28, 2012 4:30 PM | 15 seconds read

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Horizon Pharma (NASDAQ: HZNP) today announced it has filed a patent infringementlawsuit in the United States District Court for the District ofDelaware against Par Pharmaceutical, and related to anAbbreviated New Drug Application that Par filed with theU.S. Food and Drug Administration to market a generic versionof DUEXIS tablets.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsLegal

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.